Higher levels of trimethylamine N-oxide (TMAO) are independently associated with a greater prevalence of atrial fibrillation (AF), according to a study published in The Journal of Clinical Investigation. Researchers found that TMAO, a metabolite produced by gut microbes from nutrients like choline, may trigger AF by inhibiting muscarinic receptor 2 signaling and disrupting autonomic regulation … Read more
Non-endocytic transmembrane delivery strategies are emerging to bypass canonical cellular uptake routes, directly addressing the low endosomal escape efficiency that has long hindered the clinical translation of therapeutic biomacromolecules like mRNA and gene-editing tools. According to a review published in Biomedical Analysis, these advanced platforms offer a direct path to the cytosol, potentially reshaping the … Read more
Stanford Medicine researchers have identified a primary driver of biological aging: the failure of tissue-resident macrophages to clear senescent, or “zombie,” neutrophils from the body. According to a study published July 16 in Science, blocking a specific pro-inflammatory receptor, EP2, on these immune cells rejuvenated organ function and reduced age-related frailty in mice. This discovery … Read more
Research from the University of Virginia (UVA) Comprehensive Cancer Center indicates that a buildup of bile acids, triggered by an unhealthy gut microbiome, can drive hormone receptor-positive (HR+) breast cancer to metastasize to other organs, particularly the lungs. According to Melanie Rutkowski, PhD, this mechanism suggests that FDA-approved bile acid sequestrants or microbiome replenishment could … Read more
Genetic Insights into GLP-1R and Mental Health Genetic evidence suggests that lifelong activation of the glucagon-like peptide-1 receptor (GLP-1R) may reduce risks of major depressive disorder (MDD) and bipolar disorder (BD), according to a study published in Translational Psychiatry. Researchers used Mendelian randomization (MR) to analyze data from genome-wide association studies (GWASs), linking genetic variants … Read more
New research suggests that the cardiovascular health benefits of semaglutide may be more closely tied to the drug’s dosage than to the amount of weight a patient loses. A retrospective study published in npj Cardiovascular Health found that patients reaching higher maximum doses of semaglutide—1.7 mg or greater—experienced significantly lower risks of heart failure, cerebrovascular … Read more
A systematic review published in Scientific Reports found no statistically significant increase in major congenital malformations, stillbirths, or preterm births following maternal exposure to GLP-1 receptor agonists. While the data offers “cautious reassurance” for inadvertent exposure, researchers state the evidence certainty remains low, meaning these medications are not yet considered safe for routine use during … Read more
Researchers have identified a potential therapeutic pathway for Alzheimer’s disease by targeting DNA damage within brain neurons. A study published in FEBS Open Bio reports that the molecule KCL-286 successfully repairs neuronal DNA in mouse models, simultaneously reducing brain inflammation and abnormal immune activity associated with neurodegeneration. How does KCL-286 target Alzheimer’s disease? The drug … Read more
Scientists are increasingly viewing gut microbes as active participants in hormone-driven cancers, moving beyond the traditional “estrobolome” model to define a bidirectional endocrine-microbiome axis. According to a review published in the journal npj Biofilms and Microbiomes, researchers are investigating how these microbial communities influence the metabolism of estrogen and contribute to the development of breast … Read more
The Triggering Receptor Expressed on Myeloid Cells-1 (TREM-1) is emerging as a critical amplifier of the human innate immune system, according to a review published in Current Molecular Pharmacology. Researchers from Cairo University and E-JUST University identify this receptor as a potential therapeutic target for inflammatory conditions ranging from sepsis to Alzheimer’s disease, though clinical … Read more